Catalyst Wire Dossier Catalyst Wire Dossier

Subcutaneous furosemide

furosemide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Subcutaneous furosemide, covering 2022-10-13 to 2022-10-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Utility of Subcutaneous Furosemide in Patients Presenting With Early Signs of Fluid Overload [Phase 2, Phase 3]

See pricing